- Waller deemed competent to stand trial (1/11/17)5
- Young Elvis impersonator from Bernie performs on 'Ellen DeGeneres Show' (1/12/17)
- 113 drug tests at Jackson High net one instance of illicit usage (1/11/17)14
- Two subjects of interest in 1992 homicide to take polygraph tests (1/15/17)4
- Two men shot after argument; houses also struck by bullets (1/12/17)21
- Imo's Pizza will be added to Rhodes 101 convenience store in Jackson (1/10/17)16
- Cape SportsPlex contractor offers a look at the project (1/15/17)7
- Juvenile accused of stealing, damaging playground statue (1/9/17)25
- Two Cape men recovering after shooting (1/13/17)
- Business notebook: Faithfully Fed aims for more than just food (1/9/17)4
Merck reported $12.4 billion in revenue it never collected
NEW YORK -- Merck & Co. recorded $12.4 billion in revenue from its pharmacy benefits unit over the past three years even though the subsidiary never collected the money. The news sent company stock falling Monday.
Merck, the world's third-largest drug maker, said it had followed generally accepted accounting practices and the practice didn't affect earnings since the revenue was offset in financial reports as an expense.
But its stock fell amid heightened investor suspicion about corporate accounting following debacles at Enron, WorldCom and elsewhere. On the New York Stock Exchange, Merck stock fell $1.05 a share to close at $47.81.
The revenue in question came from co-payments paid by consumers using prescription drug cards under insurance plans. The pharmacy keeps the co-payment, which covers only part of a drug's cost.
Merck counted patients' co-payments to druggists as revenue generated by its Medco unit, which handles prescriptions for 65 million Americans through retail pharmacies, a mail-order program and its Internet pharmacy.